Hostname: page-component-848d4c4894-8kt4b Total loading time: 0 Render date: 2024-07-02T05:27:40.995Z Has data issue: false hasContentIssue false
  • English
  • Français

Plasma Cholesteryl Sulfate in Friedreich's ataxia

Published online by Cambridge University Press:  18 September 2015

A.C. Nestruck ,
Y.S. Huang ,
K. Eid ,
R. Dufour ,
L. Boulet ,
A. Barbeau  and
J. Davignon
A.C. Nestruck
Affiliation:
Departments of Lipid Metabolism and Atherosclerosis Research, Clinical Research Institute of Montreal
Y.S. Huang
Affiliation:
Departments of Lipid Metabolism and Atherosclerosis Research, Clinical Research Institute of Montreal
K. Eid
Affiliation:
Departments of Lipid Metabolism and Atherosclerosis Research, Clinical Research Institute of Montreal
R. Dufour
Affiliation:
Departments of Lipid Metabolism and Atherosclerosis Research, Clinical Research Institute of Montreal
L. Boulet
Affiliation:
Departments of Lipid Metabolism and Atherosclerosis Research, Clinical Research Institute of Montreal
A. Barbeau*
Affiliation:
Department of Neurobiology, Clinical Research Institute of Montreal
J. Davignon
Affiliation:
Departments of Lipid Metabolism and Atherosclerosis Research, Clinical Research Institute of Montreal
*
Clinical Research Institute of Montreal, 110 Pine Avenue West, Montreal, Quebec, Canada, H2W IR7
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Alteration of membrane fluidity and anomalies of membrane structural proteins have been suspected in Friedreich's ataxia. Plasma lecithinxholesterol acyltransferase (LCAT) activity is also lowered in this disease, presumably because of a substrate effect. The membrane-stabilizing effect of cholesteryl sulfate (CS) and its inhibitory effect on LCAT activity prompted us to measure this substance in the plasma of Friedreich's ataxia patients as well as in normal subjects and in patients with Charlevoix-Saguenay disease. Plasma cholesteryl sulfate concentrations were significantly higher in Friedreich's ataxia, with levels above the upper limit of normal in nearly half of the cases. This increase was unrelated to age, sex or plasma cholesterol levels, but closely associated with the severity of the disease and thus considered to be secondary. A similar phenomenon (except the association with severity) was observed in Charlevoix-Saguenay ataxia. Levels also tended to be higher in first-degree relatives of Friedreich cases. The significance of these findings is discussed in the light of recent knowledge and experimental data obtained in this laboratory on rats made deficient in essential fatty acids. The highest concentrations of CS observed in Friedreich's ataxia (1097 µ-g/dL, 6 times the normal mean) was only 25% as high as the concentrations reported to inhibit LCAT activity.

Type
C—Biochemistry
Information
Canadian Journal of Neurological Sciences , Volume 11 , Issue S4 , November 1984 , pp. 631 - 636
Copyright
Copyright © Canadian Neurological Sciences Federation 1984

References

Allain, CC, Poon, LS, Chan, FCS, Richmond, W, Fu, PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20: 470–475.CrossRefGoogle ScholarPubMed
Banerjee, RK, Roy, AB (1967) The formation of cholesteryl sulphate by androstenolonesulphotransferase. BiochimBiophysActa 137:211–213.Google Scholar
Barbeau, A (1976) Friedreich’s ataxia 1976. An overview. Can J Neurol Sci 3: 389–397.CrossRefGoogle ScholarPubMed
Barbeau, A, Butterworth, RF, Ngo, T, Breton, G, Melançon, S, Shapcott, D, Geoffroy, G, Lemieux, B (1976) Pyruvate metabolism in Friedreich’s ataxia. Can J Neurol Sci 3: 379–388.CrossRefGoogle ScholarPubMed
Bartlett, GR (1959) Phosphorus assay in column chromatography. J Biol Chem 234: 466–468.CrossRefGoogle ScholarPubMed
Bergner, EA, Shapiro, LJ (1981) Increased cholesterol sulfate in plasma and red blood cell membranes of steroid sulfatase deficient patients. J Clin Endocrinol Metab 53: 221–223.CrossRefGoogle ScholarPubMed
Blache, D, Bouthillier, D, Barbeau, A, Davignon, J (1982) Plasma lipoprotein lipase and hepatic lipase activities in Friedreich’s ataxia. Can J Neurol Sci 9: 191–194.CrossRefGoogle ScholarPubMed
Bleau, G, Bodley, FH, Longpré, J, Chapdelaine, A, Roberts, KD (1974) Cholesterol sulfate. I- Occurrence and possible biological function as an amphipathic lipid in the membrane of the human erythrocyte. Biochim Biophys Acta 352: 1–9.CrossRefGoogle ScholarPubMed
Bouchard, JP, Barbeau, A, Bouchard, R, Bouchard, RW (1978) Autosomal recessive spastic ataxia of Charlevoix-Saguenay. Can J Neurol Sci 5: 61–69.CrossRefGoogle ScholarPubMed
Braun, PE, Radin, NS (1969) Interactions of lipids with a membrane structural protein from myelin. Biochemistry 8: 4310–4318.CrossRefGoogle ScholarPubMed
Butterfield, DA, Leung, PK, Markesbery, WR, Barbeau, A (1979) Evidence for an altered physical state of membrane proteins in erythrocytes in Friedreich’s ataxia. Can J Neurol Sci 6: 295–298.CrossRefGoogle ScholarPubMed
Day, NE (1969) Estimating the components of a mixture of normal distributions. Biometrika 56: 463–479.CrossRefGoogle Scholar
Dow-Walsh, DS, Mahadevan, S, Kramer, JKG, Saver, FD (1975) Failure of dietary erucic acid to impair oxidation capacity or ATP production of rat heart mitochondria isolated under controlled conditions. Biochim Biophys Acta 396: 125–132.CrossRefGoogle ScholarPubMed
Eid, K (1981) Nouvelle approche d’isolement et de mesuredu cholestéryl sulfate (CS) dans le plasma humain. Thesis for M.Sc. in Clinical Sciences, Faculty of Graduate Studies, University of Montreal.Google Scholar
Epstein, EH, Leventhal, ME (1981) Steroid sulfatase of human leukocytes and epidermis and the diagnosis of recessive X-linked ichthyosis. J Clin Invest 67: 1257–1262.CrossRefGoogle ScholarPubMed
Epstein, EH, Krauss, RM, Shackleton, CHL (1981) X-linked ichthyosis: increased blood cholesterol sulfate and electrophoretic mobility of low density lipoprotein. Science 214: 659–660.CrossRefGoogle ScholarPubMed
Eto, Y, Numaguchi, S, Tañara, T, Rennert, OM (1980) Multiple sulfatase deficiency (mucosulfatidosis): impaired degradation of labelled sulfated compounds in cultured skin fibroblasts in vivo. Eur J Pediatr 135: 85–89.CrossRefGoogle ScholarPubMed
France, JT (1979) Steroid sulfatase deficiency. J Ster Biochem 11: 647–651.CrossRefGoogle Scholar
Fredrickson, DS, Goldstein, JL, Brown, MS (1978) The familial hyperlipoproteinemias. In: The metabolic basis of inherited disease. Stanbury, JB, Wyngaarden, JB and Fredrickson, DS (eds). McGraw-Hill, New York, pp. 604–655.Google Scholar
Hamel, E, Bédard, D, Laviolette, F, Butterworth, RF, Barbeau, A (1978) Familial hyperbilirubinemia in Friedreich’s ataxia. Can J Neurol Sci 5: 101–104.CrossRefGoogle ScholarPubMed
Huang, YS, Nestruck, AC, Barbeau, A, Bouchard, JP, Davignon, J (1978) Plasma lipids and lipoproteins in Friedreich’s ataxia and familial spastic ataxia — evidence for an abnormal composition of high density lipoproteins. Can J Neurol Sci 5: 149–156.CrossRefGoogle ScholarPubMed
Huang, YS, Marcel, YL, Vezina, C, Barbeau, A, Davignon, J (1980) Lecithin-cholesterol acyltransferase activity and fatty acid composition of erythrocyte phospholipids in Friedreich’s ataxia. Can J Neurol Sci 7: 429–434.CrossRefGoogle ScholarPubMed
Huang, YS, Eid, K, Davignon, J (1981) Cholesteryl sulfate: measurement with β-sitosteryl sulphate as an internal standard. Can J Biochem 59: 602–605.CrossRefGoogle ScholarPubMed
Huang, YS, Dufour, R, Davignon, J (1983) Effect of methyl linoleate administration on phospholipid fatty acid composition and osmotic fragility of erythrocytes in essential fatty acid deficient rats. J Amer Coll Nutr2: 55–61.CrossRefGoogle ScholarPubMed
Iwamori, M, Moser, H, Kishimoto, Y (1976) Cholesterol sulfate in rat tissues. Tissue distribution, developmental change and brain subcellular localization. Biochem Biophys Acta 441: 268–279.CrossRefGoogle ScholarPubMed
Lalumiére, G, Bleau, G, Chapdelaine, A, Roberts, KD (1976) Cholesteryl sulfate and sterol sulfatase in the human reproductive tract. Steroids 27: 247–260.CrossRefGoogle ScholarPubMed
Langlais, J, Zollinger, M, Plante, L, Chapdelaine, A, Bleau, G, Roberts, KD (1981) Localization of cholesteryl sulfate in human spermatozoa in support of a hypothesis for the mechanism of capacitation. Proc Natl Acad Sci USA 78: 7266–7270.CrossRefGoogle ScholarPubMed
Massé, R, Huang, YS, Eid, K, Laliberté, C, Davignon, J (1982) Plasma methyl sterol sulfates in familial hypercholesterolemia after partial ileal bypass. Can J Biochem 60: 556–563.CrossRefGoogle ScholarPubMed
Nagakawa, M, Kojima, S (1976) Effect of cholesterol sulfate and sodium dodecyl sulfate on lecithinxholesterol acyltransferase in human plasma. J Biochem 80: 729–733.CrossRefGoogle Scholar
Pourcher, E, Barbeau, A (1980) Field testing of an ataxia scoring and staging system. Can J Neurol Sci 7: 339–344.CrossRefGoogle ScholarPubMed
Sampson, EJ, Demers, LM, Krieg, AF (1975) Fasterenzymatic procedure for serum triglycerides. Clin Chem 21: 1983–1985.CrossRefGoogle ScholarPubMed
Skipski, VP, Peterson, RF, Barclay, M (1964) Quantitative analysis of phospholipids by thin-layer chromatography. Biochem J 90:374–378.CrossRefGoogle ScholarPubMed
Wade, AP (1970) The estimation of cholesterol sulfate and cholesterol glucuronide in plasma. Clin Chim Acta 27: 109–116.CrossRefGoogle Scholar